Bakırcı, Ş. Et Al. 2023. Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?. INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES , vol.11, no.3 , 44.

Bakırcı, Ş., Kurdoğlu, M., & Khaki, A., (2023). Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?. INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES , vol.11, no.3, 44.

Bakırcı, Şükrü, MERTİHAN KURDOĞLU, And Arash Khaki. "Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?," INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES , vol.11, no.3, 44, 2023

Bakırcı, Şükrü Et Al. "Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?." INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES , vol.11, no.3, pp.44, 2023

Bakırcı, Ş. Kurdoğlu, M. And Khaki, A. (2023) . "Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?." INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES , vol.11, no.3, p.44.

@article{article, author={Şükrü Bakırcı Et Al. }, title={Can Ondansetron be an Alternative to Cabergoline for Preventing Ovarian Hyperstimulation Syndrome?}, journal={INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES}, year=2023, pages={44} }